Loading...
01/11 05:04
Loading...
Supernus Pharmaceuticals Inc (SUPN) is set to release its earnings performance on 08/05 04:00:00 in After Hours trading. Consensus forecasts predict a revenue of 154.08M and an earnings per share (EPS) of 0.34 for the . With Intellectia's exclusive AI algorithms, users can predict whether the earnings will beat or miss expectations before the report drops. Leverage this powerful tool to strategize and position your trades ahead of the earnings release!
The earnings call reveals several negative indicators: increased operating loss guidance due to Sage acquisition costs, cash reserves depletion, and unresolved supply constraints for Onapgo. Although revenue guidance was raised, the uncertainty surrounding Q4 sales and evasive management responses in the Q&A suggest potential risks. The stock is likely to react negatively, especially given the small-cap market cap, which typically shows higher volatility.
The earnings call reflects strong financial performance with increased net earnings and a healthy cash position. Product launches, particularly ONAPGO and Qelbree, show promising growth and market acceptance. The company’s optimistic guidance, strategic focus on CNS and women's health, and successful reimbursement processes are positive indicators. Despite some concerns about operating earnings and management's lack of specific details on ZURZUVAE, the overall sentiment is positive, especially with new product momentum and strategic partnerships. Given the market cap, a positive stock price movement between 2% to 8% is expected.
The earnings call shows mixed results. Financial performance is slightly positive with revenue and sales growth, but the GAAP net loss and operating loss raise concerns. The Q&A section highlights management's positive outlook on growth drivers and product differentiation, yet lacks clarity on certain operational aspects. No new partnerships or share repurchase programs were announced. The market cap suggests limited volatility, leading to a neutral prediction for stock price movement.
Supernus Pharmaceuticals Inc (SUPN) is scheduled to release its FY2025Q2 earnings report onAug 5, 2025, After Hours(approximately 4:00 PM ET). This timing allows investors to react during after-hours trading, with a conference call typically following shortly after.
Analysts' consensus predicts 154.08M in revenue and an EPS of 0.34 for Supernus Pharmaceuticals Inc's FY2025Q2.
Intellectia's exclusive AI algorithms forecast a forSupernus Pharmaceuticals Inc's FY2025Q2 earnings, with a prediction date of Aug 5, 2025. Supernus Pharmaceuticals Inc
Leverage Intellectia's AI forecast to position trades ahead of theAug 5, 2025 release—consider calls for a beat scenario or protective puts for misses. Focus on pre-market volatility, and use the scenario probabilities to build strategies around revenue and guidance updates.
Intellectia's predictions are backed by rigorous backtesting, showing a high hit rate for Beat and Miss calls compared to traditional analysis. While no forecast is 100% certain, we provide probability-based scenarios (e.g., 50% chance of a *Beat*) and detailed rationales to help you make informed decisions. Combine our insights with your strategy for the best results—it's like having a co-pilot for earnings season! Empowering users to strategize trades before reports drop.
AI Earnings Prediction uses advanced Large Language Models (LLMs) to analyze a wealth of data, including past earnings transcripts, real-time market sentiment, analyst insights, and company news from the last three months. It focuses on key indicators like revenue, EPS, and margins to predict whether a company will *Beat*, *Miss*, or remain Neutral relative to market expectations. Think of it as a super-smart analyst crunching numbers and news 24/7 to give you a trading edge!
Predictions are generated two days before a company’s earnings release (e.g., 5:00 PM ET on Feb 13 for a Feb 15 report) to capture the latest market and company data. They’re updated in real-time if significant news breaks, ensuring you get fresh insights.
Currently, AI Earnings Prediction focuses on companies with market caps above $40 billion, covering major players like SPG, AAPL, MSFT, and NVDA for the 2024-2025 earnings seasons. We prioritize high-impact stocks with robust data to ensure reliable forecasts. Stay tuned as we expand coverage to more companies based on user demand!
Each prediction includes a detailed rationale, key indicator forecasts, and scenario probabilities to guide your trades. For a *Beat*, consider buying call options or shares; for a *Miss*, explore puts or hedging strategies. The prediction card provides actionable suggestions, like specific option strikes or hedging tips, tailored to your risk tolerance. Trade smart and turn insights into profits!
